Murray Christopher K.'s Form 4 filing
Blueprint Medicines Corp (BPMC) · filed Mar 8, 2023
- Accession no.
- 0001415889-23-004566
- Filed
- Mar 8, 2023
- Trade date
- Mar 6, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $85.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Murray Christopher K.CIK 0001718648 | Officer (CHIEF TECHNICAL OPERATIONS) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 6, 2023 | Common Stock | SSaleDisposed | −1,829 | $45.71 | −$83,603.59 | 25,741 | Direct | |
| Mar 6, 2023 | Common Stock | SSaleDisposed | −46 | $44.30 | −$2,037.8 | 25,695 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.